NHS England

News

NICE recommends first CAR-T cell therapy on NHS in England

Gilead Sciences and Kite, a Gilead company, have announced that the National Institute for Health and Care Excellence (NICE) has recommended Yescarta (axicabtagene ciloleucel; axi-cel) for

Market Access

Crossed wires? Mixed messages on medicines

Leela Barham argues that the latest operational guidance for the NHS in England continues to illustrate a disconnect between the messages in big-ticket policy documents from the central gov

Healthcare

NHS Innovation and Life Sciences Commission – 2022 Report La...

Co-chaired by Lord James O’Shaughnessy and Professor Mike Bewick, former deputy national medical director of NHS England (present online), the

News

Geopolitical-uncertainty-grips-digital-health-investors

NHS Health Check to be digitised to ease GP pressure

A digital version of the NHS Health Check for 40- to 74-year-olds is to be piloted by the government as a way to lessen pressure on the nation’s GP services.

News

MHRA, NHS England make available new prostate cancer treatme...

Jointly Bayer and Orion Corporation-developed NUBEQA (Darolutamide) + Androgen Deprivation Therapy (ADT) in combination with docetaxel is to be the first prostate cancer treatment to be mad

Views & Analysis